Prevalence, awareness, treatment, and control of hypertension in the Jackson heart study

Hypertension

Volumn 51, Issue 3, 2008, Pages 650-656

  Wyatt, Sharon B ^a,b   Akylbekova, Ermeg L ^c   Wofford, Marion R ^a,b   Coady, Sean A ^d   Walker, Evelyn R ^d   Andrew, Michael E ^e   Keahey, Wanda J ^a,c   Taylor, Herman A ^a,b,c,f   Jones, Daniel W ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c JACKSON STATE UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^f TOUGALOO COLLEGE   (United States)

Author keywords

Blood pressure; Detection and control; Epidemiology; Ethnicity; Hypertension; Population

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MISSISSIPPI; NUTRITION SURVEYS; PATIENT EDUCATION AS TOPIC; PREVALENCE; SEX FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 39749119286     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.100081     Document Type: Article

References (36)

1. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:2098-2104.
2. Howard G, Prineas R, Moy C, Cushman M, Kellum M, Temple E, Graham A, Howard V. Racial and geographic differences in awareness, treatment, and control of hypertension: the Reasons for Geographic and Racial Differences in Stroke Study [see comment]. Stroke. 2006;1171-1178.
3. Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, Shea S. Racial/ethnic differences in hypertension and hypertension treatment and control in the Multi-ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2004;17:963-970.
4. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:1585-1592.
5. Ong K, Cheung B, Man Y, Lau C, Lam K. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2005. Hypertension. 2007;49:69-75.
6. Nieto FJ, Alonso J, Chambless LE, Zhong M, Ceraso M, Romm FJ, Cooper L, Folsom AR, Szklo M. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med. 1995;155:677-684.
7. Taylor HA Jr, Wilson JG, Jones DW, Sarpong DF, Srinivasan A, Garrison RJ, Nelson C, Wyatt SB. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis. 2005;15(suppl 6):S6-4-17.
8. Fuqua SR, Wyatt SB, Andrew ME, Sarpong DF, Henderson FR, Cunningham MF, Taylor HA Jr. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis. 2005;15(suppl 6):S6-18-29.
9. Wilson JG, Rotimi CN, Ekunwe L, Royal CD, Crump ME, Wyatt SB, Steffes MW, Adeyemo A, Zhou J, Taylor HA Jr, Jaquish C. Study design for genetic analysis in the Jackson Heart Study. Ethn Dis. 2005;15(suppl 6):S6-30-37.
10. Carithers T, Dubbert PM, Crook E, Davy B, Wyatt SB, Bogle ML, Taylor HA Jr, Tucker KL. Dietary assessment in African Americans: methods used in the Jackson Heart Study. Ethn Dis. 2005;15(suppl 6):S6-49-55.
11. Dubbert PM, Carithers T, Ainsworth BE, Taylor HA Jr, Wilson G, Wyatt SB Physical activity assessment methods in the Jackson Heart Study. Ethn Dis. 2005;15(suppl 6):S6-56-61.
12. Payne TJ, Wyatt SB, Mosley TH, Dubbert PM, Guiterrez-Mohammed ML, Calvin RL, Taylor HA Jr, Williams DR Sociocultural methods in the Jackson Heart Study: conceptual and descriptive overview. Ethn Dis. 2005;15(suppl 6):S6-38-48.
13. Carpenter MA, Crow R, Steffes M, Rock W, Heilbraun J, Evans G, Skelton T, Jensen R, Sarpong D. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci. 2004;328:131-144.
14. Sketris I, Metge C, Ross J, MacCara M. The use of the World Health Organization anatomical therapeutic chemical/defined daily dose methodology in Canada. Drug Inf J. 2004;38:1-8.
15. The JHS Investigators. Blood Pressure, Manual of Operations. Jackson, MS: Jackson Heart Study; 2001.
16. The JHS Investigators. Quality Control, Manual of Operations. Jackson, MS: Jackson Heart Study; 2001.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
18. Anonymous. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [see comment][published correction appears in Arch Intern Med. 1998;158:573]. Arch Intern Med. 1997;157:2413-2446.
19. Adab P, McGhee S, Hedley A, Lam T. Smoking, respiratory disease and health service utilisation: the paradox. Soc Sci Med. 2005;60:483-490.
20. Wing RR, Caggiula AW, Nowalk MP, Koeske R, Lee S, Langford H. Dietary approaches to the reduction of blood pressure: the independence of weight and sodium/potassium interventions. Prev Med. 1984;13:233-244.
21. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
22. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006;119:133-141.
23. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease [see comment]. N Engl J Med. 2001;345:1291-1297.
24. Cheung B, Ong K, Man Y, Lam K, Lau C. Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens. 2006;8:93-98.
25. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide [see comment]. Hypertension. 2004;44:398-404.
26. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000 [see comment]. JAMA. 2003;290:199-206.
27. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:1051-1058.
28. Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG, Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks [see comment]. Arch Intern Med. 2003;163:525-541.
29. Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, Casiglia E, Kerlikowske K, Coope J. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group [see comment]. Lancet. 1999;353:793-796.
30. Lang T. Factors that appear as obstacles to the control of high blood pressure. Ethn Dis. 2000;10:125-130.
31. Lloyd-Jones D, Evans J, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294:466-472.
32. Cheung B, Ong K, Man Y, Wong L, Lau C, Lam K. Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. J Clin Hypertens. 2006;8:562-570.
33. Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004;110:e7-e12.
34. Moy E, Bartman BA, Weir MR. Access to hypertensive care. Effects of income, insurance, and source of care. Arch Intern Med. 1995;155:1497-1502.
35. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res Clin Exp. 2005;28:385-407.
36. Douglas J, Ferdinand K, Bakris G, Sowers J. Barriers to blood pressure control in African Americans: overcoming the barriers is challenging, but target goals can be attained. Postgrad Med. 2002;112:51-62.